Healthcare Failure Mode and Effects Analysis 

ECRI and the Institute for Safe Medication Practices PSO's Virtual Training

November 14, 2023


Failure mode and effects analysis (FMEA) is a proactive approach for evaluating a process; it can help you assess possibilities for failure and the potential impact and identify the parts of the process that are most in need of change. FMEA includes review of steps in the process, failure modes, causes, and effects. While the methodology was not specifically developed for healthcare, it’s a commonly used causal-analysis approach to enhance care.

Learning objectives

At the conclusion of the training, participants will be able to:

  • Identify the purpose of performing a healthcare failure mode and effects analysis (HFMEA) and differentiate it from other causal methods.
  • State the steps used to scope and refine the topic and the importance of formulating a topic statement.
  • Demonstrate the steps to collect and graphically display the process, subprocesses, failure modes, and causes.
  • Identify HFMEA scoring methodologies and how to prioritize failure modes using a hazard matrix.
  • Describe the best approach for formulating actions that will decrease occurrence, increase detectability, and reduce severity of the redesigned process.
  • Reflect on the principles of effective HFMEAs using the case studies.

Event details

  • When: November 14 from 12:00 p.m. - 5:00 p.m. ET
  • Where: Link to virtual platform will be provided upon registration
  • Cost: $995 USD per person
  • Who should attend: risk managers, quality and performance improvement professionals, patient safety officers, chief nursing officers, chief medical officers, infection preventionists, administrators, directors of nursing
  • Competency level: proficient to expert

Space is limited for this event.

Registration is closed. Learn more about causal analysis resources available through ECRI


Agenda and Speakers (if applicable):

Mary C. Magee, MSN, RN, CPHQ, CPPS

Senior Patient Safety / Quality Analyst and Consultant, ECRI

In her role with ECRI and the Institute for Safe Medication Practices PSO, Mary provides liaison services for member organizations, reviews and analyzes adverse event reports, and uses the information to develop written material, continuing education programs, webinars, and presentations to educate healthcare facilities about regulatory, quality improvement, and patient safety issues. Before joining ECRI, she was Senior Director of Quality, Regulatory Affairs, and Patient Safety for a large multihospital health system. She has extensive experience leading multiple successful routine and for-cause CMS, Department of Health, and Joint Commission surveys; instituted and maintained accreditation and regulatory preparedness; and conceived and lead the successful implementation of the strategic direction for quality, safety, and performance improvement.

Robert Giannini, NHA, CPPS, CHTS – IM/CP

Patient Safety Analyst/Consultant, ECRI

Before joining ECRI, Rob held roles as a Patient Safety Officer and Nursing Home Administrator at a variety of facilities. He is a Certified Healthcare Technology Specialist as an implementation manager and clinician/practitioner consultant. He has had responsibility for providing patient safety and quality improvement leadership for medication safety initiatives and consultative services to the Department of Pharmacy, Emergency Trauma Center, Geriatric and Neurosciences Service Lines. Rob has over 30 years’ experience in administration, patient safety, quality and risk management, performance improvement, health information technology, regulatory affairs and accreditation, medication safety, and service line development.

Susan Paparella, MSN, RN

Vice President for Services, Institute for Safe Medication Practices

Before joining ISMP in 2000, Susan was Director of Critical Care and Emergency Services at a community teaching hospital outside Philadelphia and eventually became the Director of Quality, Risk Management and Education. Susan brings extensive knowledge, practical experience, and a unique nursing perspective to the evaluation of patient safety issues. Susan is responsible for ISMP’s consulting services, large group collaboratives, and the development and execution of ISMP educational programming. Since 2000, Susan has led onsite engagements across the United States and abroad to help organizations evaluate risk within medication use systems and implement changes to support safe practices and improved safety culture. Susan recently organized a national Summit on Perioperative Safety to address complex medication safety issues and lead teams through the development of Safe Practice Guidelines.